Sutro Biopharma Announces Executive and Director Changes
Ticker: STRO · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1382101
| Field | Detail |
|---|---|
| Company | Sutro Biopharma, Inc. (STRO) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-of-directors, management-appointments
TL;DR
Sutro Biopharma shakes up leadership: new CEO, CMO, GC, and a board seat for Dr. Newell.
AI Summary
On April 10, 2025, Sutro Biopharma, Inc. announced changes in its executive and director roles. Dr. William Newell was appointed as Chief Medical Officer, and Ms. Jennifer L. Williams was appointed as General Counsel and Corporate Secretary. Additionally, Mr. William H. R. Newell was appointed as Chief Executive Officer, and Dr. William Newell was appointed as Chief Medical Officer. The company also announced the election of Dr. William Newell to the Board of Directors.
Why It Matters
These executive and director changes at Sutro Biopharma could signal a strategic shift or a strengthening of leadership for future development and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key executive and director positions can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Sutro Biopharma, Inc. (company) — Registrant
- Dr. William Newell (person) — Appointed Chief Medical Officer and elected to the Board of Directors
- Ms. Jennifer L. Williams (person) — Appointed General Counsel and Corporate Secretary
- Mr. William H. R. Newell (person) — Appointed Chief Executive Officer
FAQ
What is the effective date of the reported changes?
The earliest event reported is dated April 10, 2025.
Who has been appointed as the new Chief Medical Officer?
Dr. William Newell has been appointed as the Chief Medical Officer.
Who has been appointed as the new General Counsel and Corporate Secretary?
Ms. Jennifer L. Williams has been appointed as the General Counsel and Corporate Secretary.
What other role has Dr. William Newell taken on?
Dr. William Newell has also been elected to the Board of Directors.
What is Sutro Biopharma's principal executive office address?
The address is 111 Oyster Point Blvd, South San Francisco, California, 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 by Dr. William Newell regarding SUTRO BIOPHARMA, INC. (STRO).